MI
CRDL

MMCAP International’s Cardiol Therapeutics CRDL Stock Holding History

MMCAP International’s Portfolio CRDL Stock Details CRDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20.7M Buy
15,352,317
+15,143,367
+7,247% +$15.5M 1.79% 8
2025
Q4 		$199K Sell
208,950
-84,106
-29% -$88.1K 0.02% 125
2025
Q3 		$314K Hold
293,056
– – 0.04% 101
2025
Q2 		$399K Sell
293,056
-489,569
-63% -$570K 0.05% 73
2025
Q1 		$759K Sell
782,625
-13,000
-2% -$16K 0.13% 47
2024
Q4 		$1.02M Hold
795,625
– – 0.15% 47
2024
Q3 		$1.58M Sell
795,625
-128,500
-14% -$267K 0.22% 41
2024
Q2 		$1.87M Sell
924,125
-1,642,000
-64% -$3.48M 0.26% 37
2024
Q1 		$4.64M Sell
2,566,125
-387,175
-13% -$522K 0.6% 24
2023
Q4 		$2.66M Hold
2,953,300
– – 0.49% 23
2023
Q3 		$2.64M Hold
2,953,300
– – 0.76% 17
2023
Q2 		$2.63M Sell
2,953,300
-200,100
-6% -$132K 0.87% 29
2023
Q1 		$1.54M Sell
3,153,400
-200,000
-6% -$118K 0.3% 71
2022
Q4 		$1.71M Hold
3,353,400
– – 0.17% 149
2022
Q3 		$3.45M Hold
3,353,400
– – 0.27% 140
2022
Q2 		$4.43M Buy
3,353,400
+100,000
+3% +$142K 0.35% 110
2022
Q1 		$4.98M Buy
3,253,400
+100,200
+3% +$165K 0.29% 128
2021
Q4 		$5.83M Buy
+3,153,200
New +$8.71M 0.36% 104

Other funds holding CRDL

TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
IA
Integrity Alliance Urbandale, Iowa $2.64B AUM 16.75% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

MMCAP International's CRDL Position: Q1 2026 in Review

MMCAP International increased its Cardiol Therapeutics (CRDL) stake by 7,247% in Q1 2026, buying an estimated $15.5M and bringing the position to 15,352,317 shares worth $20.7M. The position accounts for 1.79% of the portfolio, ranked #8.

MMCAP International first reported a position in CRDL in Q4 2021 and has held it in 18 quarters since. 47 funds tracked by Wall St. Rank hold CRDL as of Q1 2026.

  • MMCAP International held 15,352,317 shares of Cardiol Therapeutics worth $20.7M as of Q1 2026.
  • MMCAP International bought 15,143,367 Cardiol Therapeutics shares in Q1 2026, an estimated $15.5M.
  • Cardiol Therapeutics made up 1.79% of MMCAP International's portfolio in Q1 2026, its #8 holding.
  • MMCAP International first reported a position in Cardiol Therapeutics in Q4 2021 and has held it in 18 quarters since.
  • 47 funds tracked by Wall St. Rank held Cardiol Therapeutics as of Q1 2026.

Based on MMCAP International's 13F filing for Q1 2026, filed 15 May 2026.